Orthopaedic Hospital König-Ludwig-Haus (KLH)
Denitsa graduated with two parallel Master Degrees (Biology and Chemistry) from the University of Plovdiv, Bulgaria. Afterwards Denitsa obtained a PhD fellowship at the Max-Planck-Institute of Biochemistry, Martinsried, Germany and graduated in 2005. Then she moved to the Department of Trauma Surgery, Ludwig-Maximilians-University (LMU) in Munich, Germany where she established the Tendon Research Group. In 2012, Denitsa completed her habilitation in Experimental Surgery at the LMU. 2016 to 2021, she was Professor for Experimental Trauma Surgery and Research Director at the Department of Trauma Surgery, University of Regensburg, Germany. In October 2021, she became Professor and Chair of the Department of Musculoskeletal Tissue Regeneration, KLH & University of Wuerzburg, Germany. She has published more than 100 articles and has won multiple grants; currently, she is participating in several EU consortia (MATEGRA, ACHILLES, MEFISTO, OSTEOMET, OSTASKILLS and NetwOArk). 2018-2020, she was the President of the European Orthopaedic Research Society (EORS). 2018-2022 she served at the steering committee of the International Combined Orthopaedic Research Society (ICORS). In Sep. 2022 she was recognized as a Fellow of International Orthopaedic Research (FIOR) by ICORS.
Professor of Musculoskeletal Science
University of Southampton
Richard is Professor of Musculoskeletal Science and co-founder of the Centre for Human Development, Stem Cells and Regeneration. He has held positions in USA, AstraZeneca, and University of Oxford before being appointed to a lectureship in 1999 and, subsequently, a chair at the University of Southampton in 2004. Richard is internationally recognised for his work on skeletal biology and the mechanisms involved in skeletal stem cell differentiation and bone regeneration.
He has developed teams of clinicians and biomedical scientists to generate clinical impact. Richard has trained 53 MD and PhD interdisciplinary scientists since 2002 and published widely with breakthrough publications on skeletal stem cells, osteoarthritis and bone regeneration and holds 8 patents. In 2015, he was awarded a Doctor of Science by the University of Oxford in bone regenerative medicine. He is founder / CSO of Renovos Biologics Limited, a Fellow of the Royal Society of Biology, International Orthopaedic Research and a Fellow of the Academy of Medical Sciences.
University of Zurich (University Hospital Balgrist)
ETH Zurich (Department of Health Science and Technology)
Jess Snedeker serves as a Full Professor of Orthopaedic Biomechanics, with faculty chairs at both the ETH Zurich (Department of Health Sciences and Technology) and the University of Zurich (Medical Faculty) where he is the Vice Chair for Research in the Department of Orthopedics. Since 2015, he has served as Chief Scientific Officer of the Balgrist Campus, a federally funded center for musculoskeletal research. This national hub hosts more than 20 independent groups comprising more than 220 researchers working onsite. The Snedeker Laboratory is itself a leading research group focused on tendon mechanobiology and regenerative orthopedic surgery. The group has over 150 peer reviewed original publications in print, and has received numerous scientific awards for its work. Beyond basic research, the group actively develops and clinically translates next-generation orthopedic devices for improved patient outcomes and better quality of life.
Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering
Rice University, Houston
Antonios G. Mikos is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. His research focuses on the synthesis, processing, and evaluation of new biomaterials for use as scaffolds for tissue engineering, as carriers for controlled drug delivery, as non-viral vectors for gene therapy, and as platforms for disease modeling. His work has led to the development of novel orthopaedic, dental, cardiovascular, neurologic, and ophthalmologic biomaterials. He is the author of over 690 publications and the inventor of 32 patents. Mikos is a Member of the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, the Chinese Academy of Engineering, the Academia Europaea, and the Academy of Athens. He has been recognized by various awards including the Jensen Tissue Engineering Award of the Tissue Engineering and Regenerative Medicine International Society-Global, the Lifetime Achievement Award of the Tissue Engineering and Regenerative Medicine International Society-Americas, the Founders Award of the Society For Biomaterials, the Founders Award of the Controlled Release Society, the Acta Biomaterialia Gold Medal, the Robert A. Pritzker Distinguished Lecturer Award of the Biomedical Engineering Society, and the Marshall R. Urist Award for Excellence in Tissue Regeneration Research of the Orthopaedic Research Society. He is a Founding Editor and Editor-in-Chief of the journal Tissue Engineering.
Professor, Director of Research, Department of Orthopaedics and Rehabilitation
Oregon Health & Science University, Portland
Brian Johnstone, PhD, FIOR, FORS is a Professor and the Research Director for the Department of Orthopaedics and Rehabilitation at Oregon Health & Science University, Portland, OR, USA. Brian is a Past-President of the Orthopaedic Research Society and has served/serves on numerous grant review panels of national and international organizations, journal editorial boards and scientific advisory boards. Brian has received numerous national and international honors and awards including being elected into the inaugural class of Fellows of International Orthopaedic Research (FIOR), and that of the Orthopaedic Research Society Fellows (FORS). He is now Chair of the FIOR College. In 2017 he was given the Marshall R. Urist Award for his contributions to tissue regeneration research. His research area is skeletal tissue regeneration, and he has worked on articular cartilage, spine, meniscus and temporomandibular disc. As part of his studies, he developed and patented the method for the chondrogenic induction of adult stem and progenitor cells that is widely used in cartilage tissue engineering.
NOVA Medical School, Universidade Nova de Lisboa
Helena Canhão, MD, PhD dean of NOVA Medical School, Universidade Nova de Lisboa. Full Professor of Medicine, Coordinator of the Research Unit Comprehensive Health Research Center (CHRC), and Head of the Associated Laboratory REAL. Helena Canhão is also Senior Rheumatology Consultant, Head of the Rheumatology Unit at CHULC- Hospital Santo Antonio dos Capuchos, Lisboa. She is the President of the Medical Schools’ National Council (CEMP) for 2023-2024. She is Chair of the Advisory Council of AICIB and Chair of the Advisory Council of the Collaborative Laboratory Value for Health.
Associate Professor in the Departments of Orthopaedics & Rehabilitation, Biomedical Engineering, and Pathology & Laboratory Medicine
University of Rochester Medical Center, Rochester, NY
Alayna is an Associate Professor in the Departments of Orthopaedics & Rehabilitation, Biomedical Engineering, and Pathology & Laboratory Medicine at the University of Rochester Medical Center (URMC). Her research programs span from fundamental cell biology of tendon homeostasis and healing to clinical studies using non-invasive imaging approaches to develop personalized treatment strategies to improve tendon healing outcomes. She also directs the Histology, Biochemistry and Molecular Imaging Core in the Center for Musculoskeletal Research at URMC. In 2014 she was awarded the Goldner Pioneer Award from the American Society for Surgery of the Hand, and in 2022 was awarded the Kappa Delta Young Investigator Award, the highest early career award, from the American Academy of Orthopaedic Surgery.
Professor of Musculoskeletal Biology, Fibrobesity Research Hub
Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu
Ali Mobasheri is Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology within the Faculty of Medicine at the University of Oulu in Finland. He also holds the position of Chief Researcher and International Adviser in the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania. He is the Immediate Past President of the Osteoarthritis Research Society International (OARSI) and serves on the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). In addition, he serves as “Collaborateur Scientifique de l’Université de Liège” and Senior Strategic Advisor to the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Aging, Université de Liège, Liège, Belgium. He is a member of the International Cartilage Regeneration & Joint Preservation Society (ICRS) and serves on the translational science committee of ICRS.
Ali has held visiting professorships at Harvard University in Boston (USA), University Medical Centre Utrecht (Netherlands) and King Abdulaziz University in Jeddah (Kingdom of Saudi Arabia). He is currently a Visiting Professor at Sun Yat-sen University, Guangzhou, Guangdong, China. His current research focuses on cartilage biology, specifically cellular metabolism, ion channel physiology and biomarkers of osteoarthritis. He has published more than 350 scientific articles and review articles (334 papers in PubMed, 367 paper in Scopus). His current h-index on Scopus is 68. He is ranked as one of the top 10 leading experts in the world on osteoarthritis and cartilage on expertscape.com. Ali already leads a multidisciplinary team of researchers in Vilnius and is building a new team of researchers at the University of Oulu. His work is currently funded by the Academy of Finland, The Lithuanian Research Council, and several funding mechanisms of the European Commission (FP7, Horizon Europe, COST Action, EuroNanoMed, Innovative Medicines Initiative).
Head of the Research Professorship for Regeneration Biology
Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS),
Institute of Tendon and Bone Regeneration, Paracelsus Medical University
Andreas Traweger currently holds a Research Professorship for Regenerative Biology at the Paracelsus Medical University in Salzburg, Austria. He received his PhD in Genetics from the University of Salzburg and completed his post-doctoral training at the Samuel Lunenfeld Research Institute in Toronto, Canada. He was then R&D Manager at Baxter (Vienna, Austria) for 4 years before joining Paracelsus Medical University in 2012.
His research is interdisciplinary in nature, focusing on both fundamental science and translation for human health. He published numerous peer-reviewed manuscripts, including articles in Cell, PNAS, and Scientific Translational Medicine, holds a patent application, and serves as ad hoc reviewer for a number of renowned journals and funding bodies. His interests lie in promoting the understanding of tendon and bone biology in general and to devise novel strategies to improve tendon, ligament, and bone repair. To achieve this goal, he works together with an interdisciplinary team of biologists, veterinarians, engineers, and trauma surgeons. The Traweger group mainly undertakes research focusing on the role of neoangiogenesis, tissue and cell senescence, and inflammatory processes in tendon health and disease. Further, Andreas was co-founder of Celericon Therapeutics GmbH (2018), a biotech startup focusing on the use of MSC-derived small extracellular vesicles to improve tissue regeneration.
Program Leader Biomedical Development
AO Research Institute Davos, Graubünden,
Since 2011 Prof Boyko Gueorguiev has been in charge of Biomedical Development at the AO Research Institute Davos, which he joined in 2003. He completed his masters studies in Solid State Physics at Sofia University. His PhD work at the Bulgarian Academy of Sciences focused on the crystallographic structure and mechanical properties of thermally sprayed metallic, ceramic, and bioceramic coatings. Prof Gueorguiev’s research interests include biomechanics of bone fracture fixation, implant and joint biomechanics, and metals, ceramics, and polymers used as biomaterials in medicine. He is the author of over 220 scientific papers, one book, three book chapters, and an Editor for the Journal of Orthopedic Trauma, BMC Musculoskeletal Disorders, Medicine, Indian Journal of Orthopaedics, and the International Journal of Orthopedics. Prof Gueorguiev is Vice President of the European Orthopedic Research Society and Honorary Member of both the Bulgarian Orthopedic & Taumatology Association and the Serbian Trauma Association. He is Academic Council Member of the University Multiprofile Hospital for Active Treatment and Emergency Medicine ‘N I Pirogov’, Sofia, and Honorable Research Fellow of the Institute of Metal Science ‘Acad A Balevski’ at the Bulgarian Academy of Sciences.
Principal Investigator at the JWI & Professor for Experimental Trauma Surgery
Experimental Trauma Surgery Department, University Hospital Jena,
Britt is a biologist and holds a PhD in neurobiology from the Freie Universität Berlin, Germany. In 1999 she started her research on musculoskeletal regeneration at the Charité-Universitätsmedizin Berlin, Germany and has been a professor in the Berlin-Brandenburg Center for RegenerativeTherapies (BCRT) since 2009. In June 2018 she became head of the “Experimental Trauma Surgery” at the Jena University Hospital. Her research investigates the regeneration of the musculoskeletal system with the two main interests: 1. Osseous regeneration and infection prophylaxis and treatment and 2. Tendinopathy and tendon regeneration.
Various national and international agencies and programs support her research and she is PI in the DFG-Research Training Group Materials- Microbes-Microenvironment (DFG RTG 2723) that will start February 2023. She was awarded with several prizes and was recognized as a Fellow of the International Combined Orthopedic Research Societies (FIORS) 2022. Britt is member of several research organizations and the German ambassador for the European Orthopedic Research Societies (EORS).
Research Director and the Deputy Director of the Regenerative Medicine and Skeleton lab
University of Nantes,
Catherine Le Visage is a Research Director and the Deputy Director of the Regenerative Medicine and Skeleton lab in Nantes, France (www.rmes.univ-nantes.fr). She was trained as a Pharmacist, received her PhD in Paris then performed a post-doc in the Johns Hopkins University (USA). In 2007, she joined with a tenured position the French National Institute of Health and Medical Research. In 2013, she was appointed as a Research Director and joined the Regenerative Medicine and Skeleton laboratory in Nantes, in the “Skeletal Physiopathology and Joint Regenerative Medicine” team headed by Prof J. Guicheux.
As a group leader, her most recent works have focused on innovative hydrogels as i) carriers of cells or bioactive molecules in the context of IVD disease and osteoarthritis and ii) tools for stem cell-based organogenesis.
She is an elected member of the TERMIS-EU Council, an elected member of the French Academy of Pharmacy, an Associate Editor for Biomaterials, a member of the Editorial Advisory Board of “ACS Applied Materials & Interfaces”, and a reviewer for national and international funding agencies. She has coauthored 76 publications (h-index 34) and 11 patents, and has given 70 invited lectures/seminars at national and international conferences. WoS profile: E-5460-2011.
John and Posy Krehbiel Professor of Orthopedics, Professor of Physical Medicine and Rehabilitation
Christopher Evans PhD, DSc is the John and Posy Krehbiel Professor of Orthopedics at the Mayo Clinic, with the academic rank of Professor of Physical Medicine and Rehabilitation, Orthopedic Surgery and Molecular Medicine in the Mayo Clinic College of Medicine and Science.
Dr. Evans earned BSc, PhD and DSc degrees in genetics, microbiology and biochemistry at the University of Wales, United Kingdom. He completed a postdoctoral fellowship in molecular biology at the Free University of Brussels, Belgium and earned a MA in the history and philosophy of science at the University of Pittsburgh. He has an honorary MA from Harvard Medical School, where he is the Maurice Müller Professor of Orthopaedic Surgery Emeritus.
Dr. Evans uses his background in cell and molecular biology to study clinical problems involving bones and joints, with an emphasis on gene therapy. His research has two main areas of focus: arthritis and tissue regeneration. He and his colleagues conducted the first human clinical trial of gene therapy for arthritis and subsequently developed a gene therapy for osteoarthritis that recently completed a Phase I clinical trial at Mayo Clinic. Research into tissue regeneration applications of gene therapy focuses on bone healing, cartilage repair and tendon healing; this work is at a preclinical stage.
A former President of the Orthopaedic Research Society, Dr. Evans is a fellow of the Royal Society of Chemistry, the Royal College of Pathologists, the Orthopaedic Research Society, International Orthopaedic Research and the Learned Society of Wales. He is also an honorary member of the Croatian Orthopaedic Society and an honorary fellow of Swansea University. He has received the Kappa Delta and Nicolas Andry Awards for Orthopaedic Research, the Marshall Urist Award for Excellence in Tissue Regeneration Research and the Arthur Steindler Award for significant contributions to the understanding of the musculoskeletal system. Dr. Evans is also a recipient of the Senior Achievement Award, conferred by the American Academy of Orthopaedic Surgeons, and the Distinguished Investigator Award of the Orthopaedic Research Society. He is a co-founder of the arthritis gene therapy company Genascence Corp.
Professor/Chair of Tissue Engineering
Trinity College Dublin, University of Dublin,
Prof Daniel Kelly leads a multidisciplinary musculoskeletal tissue engineering group based in the Trinity Centre for Biomedical Engineering. The goal of his lab is to understand how environmental factors regulate the fate of adult progenitor cells and the tissues they produce. This research underpins a more translational programme aimed at developing novel tissue engineering and 3D bioprinting strategies to regenerate damaged and diseased musculoskeletal tissues. To date he has published over 200 articles in peer-reviewed journals. He is the recipient of four European Research Council awards (Starter grant 2010; Consolidator grant 2015; Proof of Concept grant 2017; Advanced grant 2021).
Full Professor at the School of Mechanical and Materials Engineering, Director of the Regenerative, Modular & Developmental Engineering Laboratory (REMODEL)
University College Dublin,
Dimitrios I. Zeugolis is Full Professor at the School of Mechanical & Materials Engineering, Principal Investigator at the Charles Institute of Dermatology, Senior Fellow at Conway Institute of Biomolecular & Biomedical Research and the Director of the Regenerative, Modular & Developmental Engineering Laboratory (REMODEL), all at the University College Dublin (UCD), Dublin, Ireland.
Dimitrios is Fellow of International Orthopaedic Research (FIOR) of the International Combined Orthopaedic Research Societies (ICORS) College of Fellows; Irish Ambassador of the European Orthopaedic Research Society (EORS); member of the Endorsement Committee of the Tissue Engineering & Regenerative Medicine International Society (TERMIS); and founder and council member of the Matrix Biology Ireland (MBI).
Dimitrios is Editor-in-Chief of Biomaterials and Biosystems (Elsevier), is editorial board member of >10 journals and acts as reviewer for >130 journals. He is Pool of Expert Board member and Core Committee member of the Biotechnology and Biological Sciences Research Council (BBSRC), UK; Review College member of Research Foundation Flanders (FWO); and serves as reviewer for >30 funding agencies.
Dimitrios has authored >100 peer-reviewed articles, >400 peer-reviewed conference papers and >15 peer-reviewed book chapters. He has chaired / co-chaired >15 conferences and >50 symposia and has acted as advisor in >25 conferences.
Dimitrios has secured 2 patents and founded 2 companies. He has conducted research for >40 companies and has been involved in the development and commercialisation of numerous food and medical device products.
Hospital Universitario La Paz in Madrid,
Eduardo García-Rey qualified from University Autónoma of Madrid Medical School and trained in Hospital 12 de October in Madrid to complete Orthopaedic Surgery and Traumatology in 2003. He read Doctoral Thesis in polyethylene wear and uncemented acetabular components in total hip arthroplasty in 2003. He also visited Mayo Clinic (Minnesota, USA, Adult Reconstruction Unit) in 2002, obtained the Fellow of the European Board of Orthopaedics and Traumatology (FEBOT) in 2003 and the Visiting EFORT Fellowship in 2004. In 2017 was selected by the European Hip Society for the American Association of Hip and Knee Surgeons Guest Fellowship. His current practice as Orthopaedic Surgeon includes lower limb reconstruction, mainly focused on hip surgery, is in Hospital Universitario La Paz in Madrid. He is also involved in Research Projects linked to Idi-Paz in Madrid (hip osteonecrosis and particle debris associated to osteolysis). He is Associate Professor in the University Autónoma of Madrid (Department of Surgery, Medical School). He is member of the Executive Board of the European Research Society, Spanish Hip Society and of the Educational Committee of the European Hip Society.
Full Professor of Experimental Orthopaedics and Trauma Surgery
RWTH Aachen University Hospital,
Elizabeth is a Full Professor of Experimental Orthopaedics and Trauma Surgery at the RWTH Aachen University Hospital (Germany). She is the head of the newly created Teaching and Research Unit at the Department of Orthopaedic, Trauma, and Reconstructive Surgery. She was trained as a Chemist and earned an M.Sc. in Materials Science and Technology at the University of Havana (Cuba). As a Marie Curie fellow at the 3B’s research group (Portugal), she was awarded her Ph.D. in Biomaterials in 2009. Since then, she habilitated in Experimental Trauma Surgery at the Technical University of Münich (Germany) and has held academic positions in Germany, the Netherlands, and the USA. She is an associate researcher with Prof. Chris Evans at the Mayo Clinic (USA) and holds visiting professorships at the Peruvian University Cayetano Heredia and the UNESCO Biomaterials chair of the University of Havana. Her achievements have been recognized with multiple awards and grants. She has over 70 publications and several book chapters. Her innovative work has been patented several times. She is a pioneer in the application of mRNA technology to tissue regeneration and holds a patent on this discovery. Her group works on developing the next generation of gene therapy medicines for the treatment of multiple musculoskeletal conditions.
Professor of Biomedical Engineering and Head of the School of Engineering and Materials Science
Queen Mary University of London,
Hazel Screen is a Professor of Biomedical Engineering and Head of the School of Engineering and Materials Science at Queen Mary University of London. Her research centres on healthy and pathological tissue structure-function behaviour and its interplay with mechanobiology, with a focus on developing new in vivo and in vitro models within which to explore fundamental tissue mechanics and biology questions, and potential therapies and treatments. Her particular expertise is in tendon health and disease, where she takes a multi-level approach to exploring tendon mechanobiology.
She also leads the UK Organ-on-a-Chip Technologies Network and co-directs the Centre for Predictive in vitro Models at QMUL, within which she leads a research group specifically focused on developing novel in vitro models of musculoskeletal tissues. Here, she integrates her expertise in mechanobiology and structure-function to develop new musculoskeletal and tendon-chip models to explore health and disease.
ICREA Research Professor, Group Leader Biosensors for Bioengineering
Institute for Bioengineering of Catalonia, Barcelona,
Javier Ramon got his PhD in the Department of Organic Chemistry at the University of Barcelona (UB). Posteriorly during their post-doc stay, he was working under the direction of professor Mizutani at Hyogo University in Japan on lithography fabrication, microfluidics and dielectrophoresis technic (2009-2011). After their post-doctoral stay (2011), he was hired by the Advanced Institute for Materials Research (AIMR) at Tohoku University as Assistant Researcher. The AIMR-WPI institute is Japan’s third most relevant institute and one worldwide material science reference. He joined the group of Prof. Matsue in the device/systems group, and in April 2013, he was promoted to Assistant Professor. In 2015 he joined as Ramon y Cajal researcher IBEC. In 2020, he became an ICREA Research Professor and is now leading the Biosensors for Bioengineering group, focused on integrating fully functional tissues with microscale biosensor technology to obtain “organs-on-a-chip”.
Hospital CUF Descobertas,
-Head of Department Orthopaedics and Traumatology (COT) at Hospital CUF Descobertas – Lisboa since 2000
-Consultor de Patologia Vertebral at Paediatric Hospital Dª Estefânia since 1998
-Head of the Paediatric Spinal Unit at Paediatric Hospital Dª Estefânia since 2001
-Chairman of the Portuguese Chapter AO-Trauma since 2010
-Expert Member of National Trauma Committee (CNT) since 2014
-Member of the Innovation Committee of JMS 2020-2021
-Member of the CUF – Innovation and Sustainability Committee since 2021
-Chairman of the Girdlestone Orthopaedic Society – Oxford 2009-2011
–Vice Chairman of the Girdlestone Orthopaedic Society – Oxford 2007-2009
-Chairman of European Board Examining Committee of the EBOT – since 2000
-Chairman of Examination Board EFORT- EBOT – since 2020
-Member of the EFORT Education Committee – since 2020
-Chairman do AO® Trauma – Portugal – 2009 to 2021
-National Delegate Union Européenne des Medicins Specialistes-Ortopédie (UEMS)/European Board of Orthopaedics and Traumatology (EBOT) 1994 -2006
-Member of Executive Committee of UEMS-Orthopaedics (European Union) 1998-2006
-National Delegate European Federation of National Associations of Orthopaedics and Traumatology (EFORT)1998-2005
– Member of Educational Committee da European Spine Society (ESS) 2013-2015
– Member of International Committee da European Spine Society (ESS) since 2014
– Chairman of Educational Examining Board EBOT / EFORT since 2018
– Member of Spine Group da EPOS since 2018
Professor of Movement Biomechanics
Humboldt Universität zu Berlin, Institute of Sport Sciences,
Kirsten Legerlotz serves as Professor of Movement Biomechanics at the Institute of Sports Science at the Humboldt-Universität zu Berlin. After graduation with degrees in sport science at the German Sport University Cologne and biology at the University of Cologne, she received her doctorate in 2006 at the Institute of Biomechanics and Orthopaedics at the German Sport University Cologne. From 2007 to 2013, she conducted research at Universities in New Zealand (University of Auckland) and England (Queen Mary University of London & University of East Anglia) in the fields of sport science, materials science and biology on the adaptation of muscles and tendons. After a detour into pharmaceutical research (Novartis, Switzerland, 2013-2014), she returned to University and Germany in October 2014. Her research focusses on the investigation of musculoskeletal adaptation and orthopaedic sports injuries (injury mechanisms, prevention, rehabilitation, immunological and hormonal effects).“
Professor in Biofabrication, Chair of the Complex Tissue Regeneration department and Scientific director of MERLN Institute for Technology-Inspired Regenerative Medicine
Prof. Dr. Lorenzo Moroni received his Ph.D. cum laude in 2006 at University of Twente on 3D scaffolds for osteochondral regeneration, for which he was awarded the European doctorate award in Biomaterials and Tissue Engineering from the European Society of Biomaterials (ESB). Since 2014 he works at Maastricht University, where he is a
founding member of the MERLN Institute for Technology-Inspired
Regenerative Medicine. In 2016, he became full professor in
biofabrication for regenerative medicine. Since 2019, he is chair of
the Complex Tissue Regeneration department. He was vice-director
of MERLN from 2019 till 2022. Since 2022, he is director of MERLN.
In 2014, he received the Jean Leray award from the ESB and an ERC starting grant. In 2016, he also received the Robert Brown Award from TERMIS. In 2017, he was elected as faculty of the Young Academy of Europe and in the top 100 Italian scientists within 40 worldwide by the European Institute of Italian Culture.
His research group interests aim at developing biofabrication technologies to generate libraries of 3D scaffolds able to control cell fate, with applications spanning from skeletal to vascular, neural, and organ regeneration. From his research efforts, 3 products have already reached the market.
Professor of Spine Research, Director of the Division of Orthopaedic Research, and Director of the Cell Biology and Regenerative Medicine
Sidney Kimmel Medical College, Thomas Jefferson University,
Dr. Makarand V. Risbud is the James J. Maguire Jr. Professor of Spine Research, Director of the Division of Orthopaedic Research, and Director of the Cell Biology and Regenerative Medicine Graduate Program at Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Risbud has more than 160 peer-reviewed publications to his credit and has pioneered studies on the adaptation of nucleus pulposus cells to the unique hypoxic and hyperosmolar microenvironmental niche of the intervertebral disc. He serves on the editorial boards of many scientific journals, and on NIH grant review panels. He has served as the Chair and the Research Chair of the ORS Spine section and is the founding member of the Philadelphia Spine Research Society organizing biannual ORS-PSRS International Spine Research Symposia. He is the recipient of Henry Farfan Award by the North American Spine Society (NASS) for his outstanding contributions to basic spine research and The Professor Fredric Rieders Faculty Prize in Graduate Education by Jefferson College of Life Sciences.
Program Leader Regenerative Orthopaedics, Focus Area Leader Progenitor Cell Biology and Mechanoregulation
AO Research Institute Davos, Davos Platz,
Prof. Martin Stoddart, FRSB is Program Leader, responsible for the Regenerative Orthopaedics Program at the AO Research Institute Davos (ARI), Switzerland. His interests include the use of patient derived mesenchymal stem cells (MSCs) for bone and cartilage repair, in particular the role of mechanoregulation during the initiation of MSC chondrogenesis. This has led to an increased understanding of chondrogenesis under complex physiological loads in the absence of exogenous growth factors. He completed his bachelors in Biology in 1995 and M.Phil in 1996 at the University of Aberystwyth, Wales, UK. He completed his doctoral thesis in Oncology (University of Nottingham, UK) in 1999. In 2000 he moved to the Laboratory for experimental cartilage research, Zürich, Switzerland, before moving to ARI in 2005. He is Professor at the Albert-Ludwigs University, Freiburg, Germany and Honorary Professor at Keele University, UK. In 2016 he was elected Fellow of the Royal Society of Biology (FRSB). He was recipient of the 2020 TERMIS-EU mid-term Career Award and was inducted as a Fellow of the International Combined Orthopeadic Research Societies (FIOR) in 2022. He is the author of over 160 scientific papers and book chapters with a H-index of 43. He has mentored over 60 trainees, including 11 PhD students and has been invited to speak at over 90 national and international meetings.
Full professor for experimental trauma surgery, Vice-director of the MERLN Institute and interim chair of the department of Instructive Biomaterial Engineering
Martijn van Griensven (1974) studied in Leiden (NL) and was trained in Hannover (D). He was appointed as full professor for experimental trauma surgery in 2002 and at that time he was the youngest professor in Germany. In 2005, he became co-director of the LBI for Experimental and Clinical Traumatology in Vienna (A). In 2011, he was appointed as director of Experimental Trauma Surgery at the Technical University of Munich (D). Since September 2019, he is full professor of regenerative medicine and head of the department of Cell Biology-Inspired Tissue Engineering of the MERLN Institute at Maastricht University (NL). Since February 2022, he is vice-director of the MERLN Institute and interim chair of the department of Instructive Biomaterial Engineering. He is also affiliated to the Musculoskeletal Gene Therapy Research Group (Prof. Chris Evans), Mayo Clinic, Rochester, MN, USA. He is a visiting professor at UPCH in Lima (Peru). He is professor at the UNESCO chair for biomaterials, Universidad de la Habana (Cuba). His research areas are related to engineering methods (including gene and transcript therapy) for the musculoskeletal system with a strong pathway from pathogenetic causes to translational medicine. He has published 329 peer reviewed papers, 3 patents, 28 book chapters and he has edited 4 books. His h-factor is 68 (Scholar). He successfully supervised 59 doctoral theses and 25 master theses. He serves currently on the council of TERMIS-EU and is vice president of the section basic research of the German society for orthopaedics and trauma surgery.
Professor of Orthopaedic Surgery and Musculoskeletal Science
University of Glasgow,
Neal L Millar PhD FRCSEd (Tr&Orth) is Professor of Orthopaedic Surgery and an Academic Consultant Orthopaedic Surgeon based at the University of Glasgow, specialising in shoulder surgery and tendon injuries having completed fellowships in Sydney and New York. His laboratory’s research focuses on the immunopathogenesis and translational immunobiology of soft tissue musculoskeletal diseases including tendinopathy. He has been instrumental in leading/designing clinical trials of novel therapies in human tendon disease. He has completed a worldwide Phase II clinical trial of IL-17A blockade in shoulder tendinopathy patients following his laboratory discovery of a key role of IL-17 in tendon disease. Furthermore his discovery of a single microRNA-dependent regulatory pathway in early tissue healing highlights a microRNA replacement therapy as a promising therapeutic option for human tendon disease currently Phase I human development representing true ‘translational’ science. Additionally, he runs a specialist ‘One stop’ complex tendon clinic in the NHS focused on improving the treatment of tendinopathy.
Professor and Head of Children´s Orthopedics
Aalborg University Hospital,
My journey into the Children´s Orthopedics began in 2009 when I started working at Aarhus University Hospital immediately after finishing my residency in orthopedics. In 2014 I moved to London with my family to work as a clinical fellow at Great Ormond Street Hospital for Children (GOSH) and Royal London Hospital. I was appointed professor and Head of Children´s Orthopedics in Aalborg in 2019.
Current research areas are limb deformity correction, hip preservation in adolescents with severe hip disease and validation of a new screening strategy for hip dysplasia in newborns. By using guided growth, bony deformities can be corrected by minimal invasive surgery in the outpatient clinics instead of hospitalized treatments with osteotomies and osteosynthesis. I have been involved in testing several surgical techniques in animal in vivo models translating into clinical studies and has also been involved in basic studies of the growth plate morphology involving histological and advanced MRI analysis.
Professor of Equine Orthopaedics, President-Elect British Equine Veterinary Association, Large Animal Imaging Associate of the European College of Veterinary Diagnostic Imaging
Dept. of Clinical Sciences and Services, The Royal Veterinary College, London,
Roger Smith MA, VetMB PhD DEO FHEA DipECVSMR DipECVS FRCVS, is Professor of Equine Orthopaedics at the Royal Veterinary College (RVC) with particular interests in orthopaedic surgery, imaging, lameness, and tendon research. He qualified with a First from Cambridge University in 1987. After 2 years in general practice, he undertook a residency in equine surgery at the RVC and then a PhD on the extracellular matrix of equine tendons. He remained at the RVC and was appointed Professor in December 2003. He holds the Diploma of Equine Orthopaedics, is Diplomate of two European Specialist Colleges (Veterinary Surgery (ECVS) and Veterinary Sports Medicine and Rehabilitation), and is a Royal College of Veterinary Surgeon’s Specialist in Equine Surgery. He was awarded an RCVS Fellowship in 2016 and was ECVS President in 2017. He is currently President-Elect of British Equine Veterinary Association.
Associate Professor in Bioengineering Bone
Department of Biomedical Engineering, Eindhoven University of Technology,
Sandra is Associate Professor in Bioengineering Bone at the Eindhoven University of Technology and a core member of the Institute for Complex Molecular Systems. After obtaining her MSc in Pharmaceutical Sciences (University of Basel) and a scientific visit to Prof. David Kaplan’s lab at Tufts University in Boston, she completed her PhD (with distinction) at the Swiss Federal Institute of Technology (ETH) in Zürich in 2007. Subsequently, she moved to ETH’s Institute for Biomechanics to focus her studies on imaging methods and bioreactor design. In 2010 Sandra became group leader of the Skeletal Tissue Engineering Group as a Senior Research Associate at the Department for Health Sciences and Technology at ETH Zürich. She was appointed assistant professor at the Eindhoven University of Technology in 2013. She has won a number of prestigious personal grants and has been a board member of the Eindhoven Young Academy of Engineering and the Centre for Unusual Collaborations. Sandra has mentored many scientists and their combined work has resulted in >80 publications in renowned scientific journals.
Donald and Mary Clark Distinguished Professor of Orthopaedics and Biomedical Engineering, and the Associate Director of the Center for Musculoskeletal Research (CMSR) University of Rochester.
Hani Awad, PhD is The Donald and Mary Clark Distinguished Professor of Orthopaedics and Biomedical Engineering, and the Associate Director of the Center for Musculoskeletal Research (CMSR) at the University of Rochester. Research at the Awad Lab lies at the intersection of engineering, biology, and medicine, with a focus on understanding, diagnosing, and engineering solutions for musculoskeletal conditions. Current research interests include novel in vitro human microphysiological systems of fibrovascular-inflammatory interactions in acute and chronic tendon injuries, bone infection management and regeneration of massive bone defects using 3D printed biomaterial scaffolds, and non-Invasive multimodal measures of bone health as clinically translatable predictors of fracture risk in osteoporosis. Dr. Awad authored more than 150 peer-reviewed publications and several book chapters and patents, along with more than 75 invited speaker engagements nationally and internationally. He received several honors including the Kappa Delta Award in 2007 for work on Functional Tissue Engineering for Tendon Repair. Dr. Awad is an elected fellow of the American Institute of Medical and Biological Engineers (FAIMBE) for his contributions to the field of Tissue Engineering, and a Fellow of International Orthopaedic Research (FIOR) for contributions to orthopaedic and musculoskeletal science. He is also the Chair of the Research Council and a Board of Directors member of the Orthopaedic Research Society.
Associate Professor of Anatomy and Experimental Orthopaedics
Head of Biomaterials and Molecular Musculoskeletal Research
RWTH Aachen University.
Holger graduated in Microbiology and Gene Technology at the University of Bielefeld. After receiving a PhD in Biology, he spent time at the Dept. of Molecular Genetics at the University of Groningen, at Stanford University Medical Center, and with the Depts. of Internal Medicine and Orthopaedics at the Erasmus MC University Medical Center. In 2013, he returned to Germany as head of Orthopaedic research in Aachen, where he became Associate Professor in Experimental Orthopaedics. Upon his Board-certification as anatomist, he additionally became Associate Professor in Human Anatomy. He holds honorary positions with the Dept. of Orthopaedics in Maastricht and the section Biomaterials & Tissue Biomechanics at the Dept. of Mechanical, Maritime and Materials Engineering of the Delft Technical University and got recently appointed as research group leader in Bionics at the Institute of Structural Mechanics and Lightweight Design of the RWTH Aachen University. He works on musculoskeletal regeneration, with a broad interest in bone, cartilage, tendon and muscle pathologies and biomaterial development. His work has been recognized by various awards, including an innovation award for pioneering additive manufacturing of absorbable metallic bone implants. He published 100+ peer-reviewed articles, holds patents in the field, and participated in several large EU consortia on osteoarthritis and bone regeneration. He is steering committee member of the Internationally Combined Orthopaedic Research Societies (ICORS) and currently serves as President of the European Orthopaedic Research Society (EORS).
Clinical Director of Clínicas Espregueira – FIFA Medical Centre of Excellence and Professor of Orthopaedics and Locomotor System
– Clinical Director of Clínicas Espregueira – FIFA Medical Centre of Excellence (the only FIFA centre of excellence in Portugal and the 1st in the Iberian Peninsula)
– Professor at the University of Minho responsible for Orthopaedics and Locomotor System
– President elected of the International Society of Arthroscopy, Knee Surgery and Sports Traumatology (ISAKOS) 2025-2027
– President of the European Society for Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) (2012-2014).
– Founder and President of ESSKA Foundation (2013-2015).
– Member of the FC Porto Advisory Board
– Member of the Patellofemoral Foundation Board of Directors
– Member of the Board of FIFA MCE
– Collaborating researcher at 3B’s/ICVS – University of Minho
– President of Dom Henrique Research Center
– President of the Portuguese Society of Arthroscopy and Sports Traumatology (SPAT) (2004- 2008)
– More than 700 international conferences - More than 200 international publications, 20 Nature/Springer books and 84 chapters
Henry Ruppenthal Family Professor of Orthopaedic Surgery and Bioengineering and Associate Chair for Research, Department of Orthopaedic Surgery
University of Michigan Medical School.
Dr. Hankenson is the Henry Ruppenthal Family Professor of Orthopaedic Surgery and Bioengineering and Associate Chair for Research, Department of Orthopaedic Surgery at the University of Michigan Medical School. He received his DVM from the University of Illinois (1992), MS from Purdue University (1997) and PhD from the University of Washington (2001). A former equine veterinarian, he began his independent research career at the University of Michigan in 2002 as a faculty member in the Orthopaedic Research Laboratories (ORL). In 2006 he moved to the University of Pennsylvania, where he was the inaugural holder of the Dean W. Richardson Chair for Equine Disease Research. He returned to Michigan in 2017 as a Professor of Orthopaedic Surgery. Dr. Hankenson is an American Society for Bone and Mineral Research (ASBMR) Young Investigator award winner (2002), received a John Haddad Fellowship from the ASBMR (2003), and in 2008 was the first veterinarian awarded the Fuller Albright award by the ASBMR. Dr. Hankenson has published over 125 peer-reviewed manuscripts. He has been a permanent member of several national and international grant review study sections (NIH, VA, FWO) and is the current President of the Orthopaedic Research Society (ORS). He has received over $25 million dollars in extramural funding since 2002. Programmatically, his laboratory studies osteoblast differentiation. He is focused on translating novel basic research findings to clinically applicable therapies to heal and restore lost bone.
Assistant Professor of Orthopaedic Surgery and Bioengineering in the McKay Orthopaedic Research Laboratory
University of Pennsylvania.
Nathaniel (Nat) Dyment is an Assistant Professor of Orthopaedic Surgery and Bioengineering in the McKay Orthopaedic Research Laboratory at the University of Pennsylvania. He received his PhD in the Functional Tissue Engineering laboratory under the direction of Dr. David Butler at the University of Cincinnati and completed his postdoctoral training in musculoskeletal biology with Dr. David Rowe at UConn Health. His research program is directed towards understanding the genetic, cellular, and mechanical mechanisms that regulate normal development, disease, and repair of tissues in the joint. He has previously served as Membership and Education Chairs in the Tendon Research Section within the Orthopaedic Research Society in addition to serving as Co-Chair of the ORS Tendon Section Conference in 2022 and guest editor in the Journal of Orthopaedic Research. He was awarded a K99/R00 award from the National Institutes of Health to establish his independent program and has continued this track of successful research funding, including serving as research project lead in the recently founded Penn Achilles Tendinopathy Center of Research Translation.
Full professor of Biomedical Engineering Lund University
Prof Hanna Isaksson joined Lund University in 2011, and become full professor in 2018. Her research area is primarily musculoskeletal tissue biomechanics and mechanobiology, focusing on functional imaging and statistical shape modeling of bone, characterization of bone damage and fracture mechanisms as well as on improvement of bone quality during fracture repair. She also has ongoing research in cartilage and tendon biomechanics and mechanobiology. For more details on the research, please visit the research pages.
Prior to joining Lund University, Prof Isaksson spend three years as a post-doctoral researcher at the Biophysics of Bone and Cartilage research group, University of Eastern Finland, working on experimental methods to determine bone quality in metabolic bone diseases, primarily osteoporosis. She obtained her PhD in Biomedical Engineering from Eindhoven University of Technology, the Netherlands, in a collaborative project between TU/Eindhoven and the AO Research institute in Davos, Switzerland. The project focused on mechanobiological modeling of bone regeneration.
Head of Tissue Engineering Research Group
Chair of Department of Biomedicine
University Hospital Basel
University of Basel
Prof. Dr. Ivan Martin studied Biomedical Engineering at the University of Genova where he obtained his PhD in 1996. Between 1996 and 1999 he was a postdoctoral associate at Harvard/MIT. He joined the Department of Biomedicine (DBM) at the University Hospital of Basel in 1999 as leader of the Tissue Engineering Research Group, in close coordination with the surgical units. In 2007 he was appointed Professor for Tissue Engineering at the University of Basel and from 2021 he is Director of the DBM. From 2004 to 2009 he was the first president of the European section of the Tissue Engineering Regenerative Medicine International Society (TERMIS), and later Chair of the TERMIS Strategic Alliance Committee. In 2018 he was elected as member of the Swiss Academy of Medical Sciences. He is currently Chair of the ‘Mesenchymal stromal cell committee’ and member of the ‘Orthopaedics and Musculoskeletal Committee’ of the International Society for Cellular and Gene Therapy (ISCT). He is part of the editorial boards of 6 international journals. His group includes scientists from the biological, engineering and clinical fields, dedicated to develop solid scientific basis for innovative translational strategies in regenerative surgery. In this field he is author of more than 300 peer-reviewed papers on international journals (H-index of 99), inventor on 12 patent applications and recipient of grants from the main funding bodies, including the prestigious European Research Council. The developed science and technology have been translated into different clinical trials for cell-based cartilage and bone repair, and into the founding of a spin-out company for the commercialization of bioreactors for 3D cell culture (Cellec Biotek AG).
Director, AO Research Institute Davos (ARI), Executive Director AO R&D
AO Foundation, Davos
Geoff has worked at the AO Foundation in Davos, Switzerland since 1991. Since 2009 he has been the director of AO Research Institute Davos (ARI) and since 2020 the executive director Research & Development world-wide. The ARI has over 100 multidisciplinary scientists, engineers and medical fellows undertaking cutting-edge translational research in orthopaedics (areas: regenerative medicine, tissue engineering, infection, stem cell research, biomaterials, biomechanics and implant science). Over 70% of the ARI budget comes from the AO Foundation’s endowment created from ARI patents. Geoff’s research work on metal implant surfaces in was translated to major global improvements in the design and manufacture of fracture fixation products. In 1999 Geoff co-founded eCM journal, arguably the first online only, open access journal in the world, a pioneer in open access publishing. This concept disrupted the publishing field in science, which is now standard practice. He is a member of the International Combined Orthopaedic Research Societies (ICORS) Steering Committee and in 2016 he founded the International College of Fellows for ICORS. He won the inaugural ICORS Transformative Contribution Award in 2022. He is currently chair of the Chair of International Fellows of Tissue Engineering and Regenerative Medicine. He holds a lifetime Professor at the Faculty of Medicine, University of Freiburg (DE). He also holds honorary professorships at Cardiff and Aberystwyth universities in Wales (UK). He has been awarded several Fellowships, the most prestigious being Fellow of the Learned Society of Wales ((FLSW) the national academy for arts and sciences). He is also a Fellow of Biomaterials Science and Engineering (FBSE), of International Orthopaedic Research (FIOR), of Orthopaedic Research Society (FORS) and of Tissue Engineering and Regenerative Medicine (FTERM). Prof Richards is ranked among the 1% most-cited scientists in the world regardless of scientific discipline (compiled by Stanford University).
Full Professor in Connective Tissue Regeneration at Erasmus MC Rotterdam in the Netherlands and co-appointed as Medical Delta Professor
Delft University of Technology
Gerjo van Osch, PhD, is Full Professor in Connective Tissue Regeneration at Erasmus MC Rotterdam in the Netherlands and co-appointed as Medical Delta Professor at Delft University of Technology. She studied Medical Biology, received a PhD for research on animal models for osteoarthritis and then became involved in cartilage tissue engineering. She has set up a multi-disciplinary research group at Erasmus MC Rotterdam that focusses on cellular mechanisms in cartilage degeneration and repair. The research involves tissue engineering of the osteochondral unit as well as disease models for osteoarthritis. Gerjo has supervised more than 40 PhD students and postdocs and co-authored over 250 publications. She has been involved as PI and coordinator in (inter)national research projects and has been active in various committees and boards. Next to leading her research group she hold a position as vice dean of research at Erasmus MC, and currently is vice-chair of the Gordon Conference Cartilage Biology and Pathology and past-chair of TERMIS-EU.
University Center of Orthopaedic, Trauma and Plastic Surgery,
University Hospital Carl Gustav Carus at Technische Universität Dresden,
Fetscherstraße 74, Dresden 01307,
Stefan Zwingenberger studied medicine at the Technical University of Dresden. Since 2010, he is working at the University Center for Orthopaedics, Trauma and Plastic Surgery in Dresden, currently in the position as a senior physician for spine surgery. In 2011-2012, he spent a research stay in the laboratory of Prof. Goodman at Stanford University. His clinical focus is on the treatment of traumatic and degenerative spinal diseases. Scientifically, Stefan Zwingenberger works with his team and a broad international network of research collaborates on new methods and materials for the treatment of bone defects. Since 2015, he is the medical director of the basic research laboratory of the Center for Translational Bone, Joint and Soft Tissue Research in Dresden.
DVM, PhD, ECVS – Group Leader
Alicia El Haj
Interdisciplinary Chair of Cell Engineering
Director of the Institute of Translational Medicine
Healthcare Technology Institute, University of Birmingham, Birmingham
Professor Alicia El Haj, FREng, FRSB, FEAMBES, Interdisciplinary Professor of Cell Engineering, joined the Healthcare Technology Institute in the Institute of Translational Medicine at Birmingham University, UK in September 2018. Previously, she has been the founding Director of the Institute of Science & Technology in Medicine at Keele University Medical School. She is a leading figure in Bioengineering and Regenerative Medicine and has been involved in bringing together interdisciplinary groups within biomedicine, physical sciences and engineering interested in aspects of cell and tissue engineering and regenerative medicine to move innovative new cell based therapies to the clinic. She has published over a 200 publications in novel tissue engineering approaches such as biomechanics, bioreactors, and imaging systems for the delivery of cell therapies to the clinic with funding from EPSRC, MRC, BBSRC, AR UK and an ERC Advanced Award in 2018. She is also Director of a spin out company MICA Biosystems , Ltd involved in translating innovative in vitro pharma screening tools and stem cell control systems into clinical use.
She is Deputy Director of the MRC UKRMP Regen Med Hub and a partner in ARUK Centre in Tissue Engineering and Regenerative Medicine as well as multiple EU programmes. She has been a Research Director of an EPSRC Doctoral Training Centre in Regenerative Medicine, and a co-director of the EPSRC Centre for Innovative Manufacturing Centre in Regenerative Medicine. Prof. El Haj is ex-Chair of the European Council for the Tissue Engineering & Regenerative Medicine International Society (TERMIS).She was awarded with a Royal Society Merit Award in 2014 and is a Fellow of the Royal Academy of Engineering in the UK. In March 2015, she was awarded the MRC Suffrage Award for her role in leading women in STEM. Alicia actively engages in public events having presented ‘Remote Control Healing’ at the Café Scientifique in Royal Society London and at the ‘Next Big Thing’ at the Hay Festival 2017.
Professor of Biofabrication in Translational Regenerative Medicine, Head of Research at the Department of Orthopaedics, University Medical Center Utrecht and the Department of Clinical Sciences, University of Utrecht
Professor Jos Malda holds the Chair of Biofabrication in Translational Regenerative Medicine at Utrecht University. He is Head of Research at the Department of Orthopaedics (UMC Utrecht). He also leads the Utrecht Biofabrication Facility, where he pioneers in the field of biofabrication and its application for the treatment of musculoskeletal conditions.
Professor Malda received his Master degree in Bioprocess Engineering from Wageningen University (1999) and completed his PhD on Cartilage Tissue Engineering in 2003 (University of Twente). After a postdoctoral fellowships at the University of Twente and Queensland University of Technology, he was awarded a fellowship (NWO Veni) in 2007 that allowed him to establish his research group in Utrecht. Dr. Malda has published over 200 articles in peer-reviewed international journals (overall in the 88 citation percentile), attracted over 25 million Euro in research funding, including funding from the NIH and the ERC. Further, he is vice-chair of the Regenerative Medicine program in Utrecht and one of the initiators of the first international master’s program in Biofabrication.
He is the Past President of the International Society for Biofabrication (ISBF; 2014-2018) and the current Secretary General of the International Cartilage Regeneration and joint preservation Society (ICRS). His pioneering work was recently acknowledged with the TERMIS-EU Mid Career Award (2021), the Berton Rahn Research Award (2021), the ISBF Senior Investigator Award (2021) and the Mimics Innovation Award (2022).